.
MergerLinks Header Logo

Announced

Curia to acquire LakePharma.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

United States

Single Bidder

Domestic

Friendly

Biotechnology

Private

Pending

developin biologics

Acquisition

Majority

Synopsis

Edit

Curia, a contract research, development and manufacturing organization, agreed to acquire LakePharma, a provider of biologics services intended to serve pharmaceutical and biotechnology markets. Financial terms were not disclosed. "LakePharma will expand our integrated approach to provide biotech and pharmaceutical companies with small and large molecule research, development and manufacturing solutions. Funding and innovation in the biotech sector remains strong. Our combined capabilities will enable us to partner with our customers by seamlessly providing LakePharma's multi-modality innovation and speed along with fill-finish solutions from Curia. Our agreements with LakePharma and Integrity Bio demonstrate our commitment to expanding and deepening our biologics capabilities to help our customers advance from curiosity to cure," John Ratliff, Curia Chairman & CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US